An Investigation on 3-acetyl-7-methoxy-coumarin Schiff Bases and Their Ru(ii) Metallates with Potent Antiproliferative Activity and Enhanced LDH and NO Release

Overview

Journal RSC Adv

Publisher Royal Society of Chemistry

Specialty Chemistry

Date 2022 May 11

PMID 35540910

Authors

G Kalaiarasi

S Rex Jeya Rajkumar

S Dharani

J G Malecki

R Prabhakaran

Affiliations

Soon will be listed here.

Abstract

New cyclometallated ruthenium(ii) complexes of 3-acetyl-7-methoxycoumarin-4-substituted thiosemicarbazones were synthesized and characterized by analytical and spectral techniques. The crystal structures of the ligands HL and complexes (1, 2 and 4) were confirmed by X-ray crystallography. The analysis showed that the ligands have undergone C-H activation at the C(4) carbon of the pyrone ring and acted in a tridentate fashion by binding through C, N and S atoms. CT-DNA and protein (BSA/HSA) binding studies were carried out to analyze their interaction with biomolecules. Good binding affinity with DNA was observed with intercalative binding mode, which was further confirmed by EB displacement and viscosity measurement studies. The quenching mechanism with BSA/HSA was found to be static. Three dimensional (3D) fluorescence measurements were carried out to validate the micro environmental changes in the serum albumins. Their antioxidant propensity and antimicrobial study insisted that the compounds displayed good spectrum of activity. Evaluation of their anticancer potential against MCF-7 (human breast cancer) and A549 (human lung carcinoma) cell lines revealed that the complexes exhibited better activity than the ligands and cisplatin. Further, the results of LDH and NO release assays supported the cytotoxic nature of the compounds. The non-toxic nature of the compounds was established by testing against the non-cancerous cell line HaCaT (human normal keratinocyte).

Citing Articles

Advances in Coordination Chemistry of Schiff Base Complexes: A Journey from Nanoarchitectonic Design to Biomedical Applications.

Abd-El-Aziz A, Li Z, Zhang X, Elnagdy S, Mansour M, ElSherif A Top Curr Chem (Cham). 2025; 383(1):8.

PMID: 39900838 DOI: 10.1007/s41061-025-00489-w.

Umbelliferone and Its Synthetic Derivatives as Suitable Molecules for the Development of Agents with Biological Activities: A Review of Their Pharmacological and Therapeutic Potential.

Kornicka A, Balewski L, Lahutta M, Kokoszka J Pharmaceuticals (Basel). 2023; 16(12).

PMID: 38139858 PMC: 10747342. DOI: 10.3390/ph16121732.

Antioxidant Activity of Coumarins and Their Metal Complexes.

Todorov L, Saso L, Kostova I Pharmaceuticals (Basel). 2023; 16(5).

PMID: 37242434 PMC: 10220850. DOI: 10.3390/ph16050651.

A novel water-soluble thiosemicarbazone Schiff base ligand and its complexes as potential anticancer agents and cellular fluorescence imaging.

Feizpour S, Hosseini-Yazdi S, Safarzadeh E, Baradaran B, Dusek M, Poupon M J Biol Inorg Chem. 2023; 28(5):457-472.

PMID: 37129705 DOI: 10.1007/s00775-023-02001-5.

Interaction of Conazole Pesticides Epoxiconazole and Prothioconazole with Human and Bovine Serum Albumin Studied Using Spectroscopic Methods and Molecular Modeling.

Golianova K, Havadej S, Verebova V, Ulicny J, Holeckova B, Stanicova J Int J Mol Sci. 2021; 22(4).

PMID: 33672042 PMC: 7919476. DOI: 10.3390/ijms22041925.

References

Patil S, Unki S, Kulkarni A, Naik V, Badami P . Co(II), Ni(II) and Cu(II) complexes with coumarin-8-yl Schiff-bases: spectroscopic, in vitro antimicrobial, DNA cleavage and fluorescence studies. Spectrochim Acta A Mol Biomol Spectrosc. 2011; 79(5):1128-36. DOI: 10.1016/j.saa.2011.04.032. View

Bonfoco E, Krainc D, Ankarcrona M, Nicotera P, Lipton S . Apoptosis and necrosis: two distinct events induced, respectively, by mild and intense insults with N-methyl-D-aspartate or nitric oxide/superoxide in cortical cell cultures. Proc Natl Acad Sci U S A. 1995; 92(16):7162-6. PMC: 41299. DOI: 10.1073/pnas.92.16.7162. View

Lian W, Wang X, Xie C, Tian H, Song X, Pan H . Mixed-ligand copper(ii) Schiff base complexes: the role of the co-ligand in DNA binding, DNA cleavage, protein binding and cytotoxicity. Dalton Trans. 2016; 45(22):9073-87. DOI: 10.1039/c6dt00461j. View

Qiao X, Ma Z, Xie C, Xue F, Zhang Y, Xu J . Study on potential antitumor mechanism of a novel Schiff base copper(II) complex: synthesis, crystal structure, DNA binding, cytotoxicity and apoptosis induction activity. J Inorg Biochem. 2011; 105(5):728-37. DOI: 10.1016/j.jinorgbio.2011.01.004. View

Bisceglie F, Musiari A, Pinelli S, Alinovi R, Menozzi I, Polverini E . Quinoline-2-carboxaldehyde thiosemicarbazones and their Cu(II) and Ni(II) complexes as topoisomerase IIa inhibitors. J Inorg Biochem. 2015; 152:10-9. DOI: 10.1016/j.jinorgbio.2015.08.008. View

Hartinger C, Jakupec M, Zorbas-Seifried S, Groessl M, Egger A, Berger W . KP1019, a new redox-active anticancer agent--preclinical development and results of a clinical phase I study in tumor patients. Chem Biodivers. 2008; 5(10):2140-2155. DOI: 10.1002/cbdv.200890195. View

Chow M, Licona C, Wong D, Pastorin G, Gaiddon C, Ang W . Discovery and investigation of anticancer ruthenium-arene Schiff-base complexes via water-promoted combinatorial three-component assembly. J Med Chem. 2014; 57(14):6043-59. DOI: 10.1021/jm500455p. View

Huang H, Zhang P, Chen Y, Qiu K, Jin C, Ji L . Synthesis, characterization and biological evaluation of labile intercalative ruthenium(ii) complexes for anticancer drug screening. Dalton Trans. 2016; 45(33):13135-45. DOI: 10.1039/c6dt01270a. View

Gildea R, Bourhis L, Dolomanov O, Grosse-Kunstleve R, Puschmann H, Adams P . iotbx.cif: a comprehensive CIF toolbox. J Appl Crystallogr. 2011; 44(Pt 6):1259-1263. PMC: 3236671. DOI: 10.1107/S0021889811041161. View

10.

Kostova I, Manolov I, Karaivanova M . Synthesis, physicochemical characterization, and cytotoxic screening of new zirconium complexes with coumarin derivatives. Arch Pharm (Weinheim). 2001; 334(5):157-62. DOI: 10.1002/1521-4184(200105)334:5<157::aid-ardp157>3.0.co;2-s. View

11.

Jayanthi E, Kalaiselvi S, Padma V, Bhuvanesh N, Dharmaraj N . Solvent assisted formation of ruthenium(III) and ruthenium(II) hydrazone complexes in one-pot with potential in vitro cytotoxicity and enhanced LDH, NO and ROS release. Dalton Trans. 2015; 45(4):1693-707. DOI: 10.1039/c5dt03849a. View

12.

Wiegand I, Hilpert K, Hancock R . Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances. Nat Protoc. 2008; 3(2):163-75. DOI: 10.1038/nprot.2007.521. View

13.

Datta P, Mukhopadhyay A, Manna P, Tiekink E, Sil P, Sinha C . Structure, photophysics, electrochemistry, DFT calculation, and in-vitro antioxidant activity of coumarin Schiff base complexes of Group 6 metal carbonyls. J Inorg Biochem. 2011; 105(4):577-88. DOI: 10.1016/j.jinorgbio.2010.04.013. View

14.

Demoro B, Sarniguet C, Sanchez-Delgado R, Rossi M, Liebowitz D, Caruso F . New organoruthenium complexes with bioactive thiosemicarbazones as co-ligands: potential anti-trypanosomal agents. Dalton Trans. 2011; 41(5):1534-43. PMC: 3299570. DOI: 10.1039/c1dt11519g. View

15.

LeGrand C, Bour J, Jacob C, Capiaumont J, Martial A, Marc A . Lactate dehydrogenase (LDH) activity of the cultured eukaryotic cells as marker of the number of dead cells in the medium [corrected]. J Biotechnol. 1992; 25(3):231-43. DOI: 10.1016/0168-1656(92)90158-6. View

16.

Satyanarayana S, Dabrowiak J, Chaires J . Tris(phenanthroline)ruthenium(II) enantiomer interactions with DNA: mode and specificity of binding. Biochemistry. 1993; 32(10):2573-84. DOI: 10.1021/bi00061a015. View

17.

Creaven B, Devereux M, Karcz D, Kellett A, McCann M, Noble A . Copper(II) complexes of coumarin-derived Schiff bases and their anti-Candida activity. J Inorg Biochem. 2009; 103(9):1196-203. DOI: 10.1016/j.jinorgbio.2009.05.017. View

18.

Rademaker-Lakhai J, van den Bongard D, Pluim D, Beijnen J, Schellens J . A Phase I and pharmacological study with imidazolium-trans-DMSO-imidazole-tetrachlororuthenate, a novel ruthenium anticancer agent. Clin Cancer Res. 2004; 10(11):3717-27. DOI: 10.1158/1078-0432.CCR-03-0746. View

19.

Prabhakaran R, Geetha A, Thilagavathi M, Karvembu R, Krishnan V, Bertagnolli H . Synthesis, characterization, EXAFS investigation and antibacterial activities of new ruthenium(III) complexes containing tetradentate Schiff base. J Inorg Biochem. 2004; 98(12):2131-40. DOI: 10.1016/j.jinorgbio.2004.09.020. View

20.

Kulkarni A, Patil S, Badami P . Synthesis, characterization, DNA cleavage and in vitro antimicrobial studies of La(III), Th(IV) and VO(IV) complexes with Schiff bases of coumarin derivatives. Eur J Med Chem. 2009; 44(7):2904-12. DOI: 10.1016/j.ejmech.2008.12.012. View